Latest filing published 17 Feb 2026 for Macrogenics INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Scott Koenig span 3 companies, the busiest being Macrogenics Inc, Crescent Biopharma, Inc. and Applied Genetic Technologies Corp. In total, 13 filings cover trades dated from 18 May 2021 to 15 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 17 February 2026 with an option exercise in Macrogenics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations